Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2006 / Cilt: 40 - Sayı: 1

Intradermal botulinum toxin injection for the treatment of primary focal hyperhydrosis

Fokal hiperhidrozun intradermal botulinum toksin enjeksiyonuyla tedavisi

Pages
17–19
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: Intradermal botulinum toxin injection proves to be an effective and safe choice for the treatment of primary focal hyperhydrosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and design: Primary focal hyperhydrosis, a sweating disorder of unknown cause, affects primarily the axilla, palm, sole and the forehead.
📊
Key Findings & Data:MATERIAL-METHODS: 20 localizations (10 palm, 8 axilla and 2 sole) of 10 primary focal hyperhydrotic patient was included to the study.
💡
Conclusion & Impact:CONCLUSION: Intradermal botulinum toxin injection proves to be an effective and safe choice for the treatment of primary focal hyperhydrosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and design: Primary focal hyperhydrosis, a sweating disorder of unknown cause, affects primarily the axilla, palm, sole and the forehead. Patients face pscyhological, social and occupational problems in addition to the maceration of the skin and secondary micotic infections. This study was performed to assess the efficacy of intradermal botulinum toxin injections for the treatment of primary focal hyperhydrosis. MATERIAL-METHODS: 20 localizations (10 palm, 8 axilla and 2 sole) of 10 primary focal hyperhydrotic patient was included to the study. Hyperhydrotic areas detected by the Minor starch iodine test were qualitatively analyzed before and after the treatment as well as the subjective scaling of the patients' complaints.RESULTS: Both the qualitative scores of the Minor starch iodine test and the subjective complaint score of the patients decreased significantly after the intradermal botulinum toxin injections. No systemic adverse event was noted. CONCLUSION: Intradermal botulinum toxin injection proves to be an effective and safe choice for the treatment of primary focal hyperhydrosis.

Özet

Nedeni bilinmeyen bir terleme bozukluğu olan primer fokal hiperhidroz sıklıkla koltuk altlarını, el ve ayak tabanları ile alnı tutar. Aşırı terleme sonucunda deride maserasyon ve sekonder miktotik enfeksiyonların yanında psikolojik, sosyal ve mesleki sorunlar da oluşur. Bu yazıda primer fokal hiperhidrozun tedavisinde intradermal botulinum enjeksiyonunun etkinliği araştırılmıştır. Primer fokal hiperhidrozlu 10 hastanın 20 hiperhidroz alanı çalışma kapsamına alındı. Bunların 10'u el ayası, 8'i aksilla ve 2'si de ayak tabanı idi. Tedavi öncesinde ve kontrollerde iyot nişasta ile tespit edilen hiperhidroz alanlarına 1'den 5'e kadar eşel üzerinde kalitatif değerlendirme yapıldı. Hastaların subjektif yakınmaları 1-10 arası eşel üzerinden değerlendirildi. Botulinum enjeksiyonu sonrasında gerek minor nişasta testinin kalitatif skorlarında, gerekse de hastaların subjektif yakınma skorlarında istatistiksel olarak anlamlı azalma tespit edildi. Hiçbir hastada sistemik yan etki görülmedi. İntradermal botulinum toksini enjeksiyonu primer fokal hiperhidrozun tedavisinde etkin ve güvenilir bir yöntem olarak değerlendirildi.

🔖

Cite This Article

BALABAN, D., KARAOĞLU, A., KÖŞLÜ, A., KAYIRAN, A. M. (2022). Intradermal botulinum toxin injection for the treatment of primary focal hyperhydrosis. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 40 - Sayı: 1, 17–19. https://ajindex.com/articles/622181

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Ambache N: A further survey of the action of Clostridium botulinum toxin upon different types of autonomic nevre fibers. J Physiol 1951; 113: 1-17
  2. Food and Drug Administration: 2004: http://www.fda.gov/ bbs/topics/answers/2004/ANS01301.html
  3. Brindis G, Civanello IM, Albanese A, Maria G: Gastrointestinal smooth muscles and sphincters spasms: treatment with botulinum neurotoxin. Curr Med Chem 2003 Apr;10(7): 603-23
  4. Naumann M, Hoffmann U, Bergmann I, et al Focal Hyperhidrosis: Effective treatment with intracutaneous botulinum toxin. Arch Dermatol 1998; 134: 301-4
  5. Naumann M, Lowe N.J, Kumar C.R et al: The Hyperhidrosis Clinical Investigators Group: Botulinum toxin A is a safe and effective treatment for axillary hyperhidrosis over 16 months. Arch Dermatol 2003; 139: 731-6
  6. Shelley WB, Florence R: Compensatory hyperhidrosis after sympathechtomy. N Engl J Med 1960; 263: 1056-8
  7. Lowe N.J, Yamauchi P.S, Lask G.P et al: Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: A double blind, randomized, placebo controlled study. Dermatol Surg 2002; 28 (9):822-7
  8. Naver H, Swartling C, Aquilonius S-M: Treatment of focal hyperhidrosis with botulinum toxin type A. Brief overview of methodology and 2 years' experience. Eur J Neurol 1999; 6(supp 4):S117- 20